Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 2/20 | 0.32 |
| ▸ | CA6 | P23280 | 2/20 | 0.32 |
| ▸ | CA7 | P43166 | 2/20 | 0.32 |
| ▸ | CA9 | Q16790 | 2/20 | 0.32 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.32 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | CA3 | P07451 | 1/20 | 0.32 |
| ▸ | CA4 | P22748 | 1/20 | 0.32 |
| ▸ | CA5A | P35218 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | RECQL | P46063 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5408109 | 0.81 | CA12 (0.31) | CA12CA6CA7CA9CA14 | |
| SCHEMBL1233986 | 0.71 | CA12 (0.44) | CA12CA6CA7CA9CA14 | |
| SCHEMBL27880253 | 0.68 | CA12 (0.41) | CA12CA6CA7CA9CA14 | |
| SCHEMBL9393389 | 0.66 | CA12 (0.42) | CA12CA6CA7CA9CA14 | |
| SCHEMBL19764098 | 0.66 | CA12 (0.38) | CA12CA6CA7CA9CA14 | |
| SCHEMBL539539 | 0.66 | CA12 (0.38) | CA12CA6CA7CA9CA14 | |
| SCHEMBL1336569 | 0.66 | CA12 (0.34) | CA12CA6CA7CA9CA14 | |
| SCHEMBL5410670 | 0.65 | — | — | |
| SCHEMBL16240065 | 0.65 | — | — | |
| SCHEMBL5577158 | 0.64 | CA12 (0.55) | CA12CA6CA7CA9CA14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119069696-A | Slurry composition for secondary battery positive electrode, and secondary battery | 江苏百公里新材料科技有限公司 | 2024-12-03 | — | — | CN | disclosed |
| CN-109562039-B | Hair dye composition | 株式会社漫丹 | 2022-02-15 | — | — | CN | disclosed |
| CN-109562047-B | Hair dye composition | 株式会社漫丹 | 2021-12-14 | — | — | CN | disclosed |
| CN-109562038-B | Hair dye composition | 株式会社漫丹 | 2021-10-22 | — | — | CN | disclosed |
| US-20190309132-A1 | AMINO-SUBSTITUTED POLYSILOXANES COMBINED WITH POLYMERIZABLE AND UNPOLYMERIZABLE ORGANIC ACIDS | GEORGETOWN UNIVERSITY | 2019-10-10 | — | — | US | disclosed |
| US-10221283-B2 | Amino-substituted polysiloxanes combined with polymerizable and unpolymerizable organic acids | GEORGETOWN UNIVERSITY (US) | 2019-03-05 | — | — | US | disclosed |
| US-20150361224-A1 | AMINO-SUBSTITUTED POLYSILOXANES COMBINED WITH POLYMERIZABLE AND UNPOLYMERIZABLE ORGANIC ACIDS | GEORGETOWN UNIVERSITY (US) | 2015-12-17 | — | — | US | disclosed |
| WO-2014113643-A1 | AMINO-SUBSTITUTED POLYSILOXANES COMBINED WITH POLYMERIZABLE AND UNPOLYMERIZABLE ORGANIC ACIDS | GEORGETOWN UNIVERSITY (US) | 2014-07-24 | — | — | WO | disclosed |
| EP-1207816-A4 | BIOMEDICAL COMPOSITIONS | COMMW SCIENT IND RES ORG (AU) | 2008-12-24 | — | — | EP | disclosed |
| US-7241853-B2 | Printing processes employing intermediate transfer with molten intermediate transfer materials | XEROX CORPORATION (US) | 2007-07-10 | — | — | US | disclosed |
| US-7128412-B2 | Printing processes employing intermediate transfer with molten intermediate transfer materials | XEROX CORPORATION (US) | 2006-10-31 | — | — | US | disclosed |
| US-20060204768-A1 | Printing processes employing intermediate transfer with molten intermediate transfer materials | XEROX CORPORATION | 2006-09-14 | — | — | US | disclosed |
| US-20050074618-A1 | Printing processes employing intermediate transfer with molten intermediate transfer materials | XEROX CORPORATION | 2005-04-07 | — | — | US | disclosed |
| US-20050074260-A1 | Printing apparatus and processes employing intermediate transfer with molten intermediate transfer materials | XEROX CORPORATION | 2005-04-07 | — | — | US | disclosed |
| EP-1207816-A1 | BIOMEDICAL COMPOSITIONS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2002-05-29 | — | — | EP | disclosed |
| WO-2001008603-A1 | BIOMEDICAL COMPOSITIONS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2001-02-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150361224-A1 | AMINO-SUBSTITUTED POLYSILOXANES COMBINED WITH POLYMERIZABLE AND UNPOLYMERIZABLE ORGANIC ACIDS | SLC1A1, SLC43A1, EPCAM | CA12 1154/4885CA6 1071/4885CA7 2768/4885 |
| US-10221283-B2 | Amino-substituted polysiloxanes combined with polymerizable and unpolymerizable organic acids | SLC1A1, SLC43A1, EPCAM | CA12 1154/4885CA6 1071/4885CA7 2768/4885 |
| US-20190309132-A1 | AMINO-SUBSTITUTED POLYSILOXANES COMBINED WITH POLYMERIZABLE AND UNPOLYMERIZABLE ORGANIC ACIDS | SLC1A1, SLC43A1, EPCAM | CA12 1154/4885CA6 1071/4885CA7 2768/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.